论文信息 - Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All - 字舞流文

Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All

F. Guirakhoo | T. Monath | J. Lang | S. Yoksan | R. Forrat | S. Kitchener | N. Kanesa-thasan | T. Ermak | P. Bedford | R. Nichols | M. Quentin-Millet | D. Morrison | Xiaochu Duan | K. McCarthy | N. Kanesa-Thasan